Global Blood Therapeutics, Inc.·4

Jun 3, 7:49 PM ET

CATHERS BRIAN EDWIN 4

4 · Global Blood Therapeutics, Inc. · Filed Jun 3, 2020

Insider Transaction Report

Form 4
Period: 2020-06-01
Transactions
  • Award

    Restricted Stock Units

    2020-06-01+42,40042,400 total
    Common Stock (42,400 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock.
  • [F2]The RSUs vest in installments conditioned upon the achievement, on or before June 30, 2024, of up to three specified market price thresholds of the Issuer, subject to the Reporting Person's continuous service with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION